Aprea Therapeutics, Inc. — SC 13G/A Filings
10 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Aprea Therapeutics, Inc. (APRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aprea Therapeutics, Inc. has filed 10 SC 13G/A documents with the SEC since 2019. To view all SEC filings by Aprea Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0001493152-24-005323 | Feb 7, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-023130 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-034912 | Feb 11, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-023915 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001193125-21-043381 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-022683 | Feb 16, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-021947 | Feb 12, 2021 | — |
| SC 13G/A | — | 0000315066-21-001377 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000315066-21-000803 | Feb 8, 2021 | — |
| SC 13G/A | — | 0000315066-20-000788 | Feb 7, 2020 | — |